Primary brain tumours in adults
The most frequent adult-type primary CNS tumours are diffuse gliomas, but a large variety of
rarer CNS tumour types exists. The classification of these tumours is increasingly based on …
rarer CNS tumour types exists. The classification of these tumours is increasingly based on …
European Association for Neuro-Oncology (EANO) guideline on the diagnosis and treatment of adult astrocytic and oligodendroglial gliomas
M Weller, M Van Den Bent, JC Tonn, R Stupp… - The lancet …, 2017 - thelancet.com
Summary The European Association for Neuro-Oncology guideline provides
recommendations for the clinical care of adult patients with astrocytic and oligodendroglial …
recommendations for the clinical care of adult patients with astrocytic and oligodendroglial …
Vorasidenib in IDH1-or IDH2-mutant low-grade glioma
IK Mellinghoff, MJ Van Den Bent… - … England Journal of …, 2023 - Mass Medical Soc
Background Isocitrate dehydrogenase (IDH)–mutant grade 2 gliomas are malignant brain
tumors that cause considerable disability and premature death. Vorasidenib, an oral brain …
tumors that cause considerable disability and premature death. Vorasidenib, an oral brain …
Isocitrate dehydrogenase (IDH) mutant gliomas: a Society for Neuro-Oncology (SNO) consensus review on diagnosis, management, and future directions
JJ Miller, LN Gonzalez Castro, S McBrayer… - Neuro …, 2023 - academic.oup.com
Isocitrate dehydrogenase (IDH) mutant gliomas are the most common adult, malignant
primary brain tumors diagnosed in patients younger than 50, constituting an important cause …
primary brain tumors diagnosed in patients younger than 50, constituting an important cause …
EANO guidelines for the diagnosis and treatment of meningiomas
R Goldbrunner, G Minniti, M Preusser… - The Lancet …, 2016 - thelancet.com
Although meningiomas are the most common intracranial tumours, the level of evidence to
provide recommendations for the diagnosis and treatment of meningiomas is low compared …
provide recommendations for the diagnosis and treatment of meningiomas is low compared …
Temozolomide chemotherapy versus radiotherapy in high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup study
BG Baumert, ME Hegi, MJ van den Bent… - The Lancet …, 2016 - thelancet.com
Background Outcome of low-grade glioma (WHO grade II) is highly variable, reflecting
molecular heterogeneity of the disease. We compared two different, single-modality …
molecular heterogeneity of the disease. We compared two different, single-modality …
Maximizing safe resection of low-and high-grade glioma
SL Hervey-Jumper, MS Berger - Journal of neuro-oncology, 2016 - Springer
Surgical resection plays a central role in the management of gliomas. In this study, we
review the evidence in support of extent of resection to improve survival, symptom …
review the evidence in support of extent of resection to improve survival, symptom …
Adjuvant procarbazine, lomustine, and vincristine chemotherapy in newly diagnosed anaplastic oligodendroglioma: long-term follow-up of EORTC brain tumor group …
MJ Van Den Bent, AA Brandes… - Journal of clinical …, 2013 - ascopubs.org
Purpose Anaplastic oligodendroglioma are chemotherapy-sensitive tumors. We now present
the long-term follow-up findings of a randomized phase III study on the addition of six cycles …
the long-term follow-up findings of a randomized phase III study on the addition of six cycles …
Temozolomide chemotherapy alone versus radiotherapy alone for malignant astrocytoma in the elderly: the NOA-08 randomised, phase 3 trial
Background Radiotherapy is the standard care in elderly patients with malignant
astrocytoma and the role of primary chemotherapy is poorly defined. We did a randomised …
astrocytoma and the role of primary chemotherapy is poorly defined. We did a randomised …